Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults

BACKGROUND:. Ischemia-reperfusion injury is common in critically ill patients, and directed therapies are lacking. Inhaled hydrogen gas diminishes ischemia-reperfusion injury in models of shock, stroke, and cardiac arrest. The purpose of this study was to investigate the safety of inhaled hydrogen g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexis R. Cole, BS, Francesca Sperotto, MD, James A. DiNardo, MD, Stephanie Carlisle, Michael J. Rivkin, MD, Lynn A. Sleeper, ScD, John N. Kheir, MD
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/cf8b816444ae4276b11b19d4aaec888d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cf8b816444ae4276b11b19d4aaec888d
record_format dspace
spelling oai:doaj.org-article:cf8b816444ae4276b11b19d4aaec888d2021-11-25T07:56:43ZSafety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults2639-802810.1097/CCE.0000000000000543https://doaj.org/article/cf8b816444ae4276b11b19d4aaec888d2021-10-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000543https://doaj.org/toc/2639-8028BACKGROUND:. Ischemia-reperfusion injury is common in critically ill patients, and directed therapies are lacking. Inhaled hydrogen gas diminishes ischemia-reperfusion injury in models of shock, stroke, and cardiac arrest. The purpose of this study was to investigate the safety of inhaled hydrogen gas at doses required for a clinical efficacy study. DESIGN:. Prospective, single-arm study. SETTING:. Tertiary care hospital. PATIENTS/SUBJECTS:. Eight healthy adult participants. INTERVENTIONS:. Subjects underwent hospitalized exposure to 2.4% hydrogen gas in medical air via high-flow nasal cannula (15 L/min) for 24 (n = 2), 48 (n = 2), or 72 (n = 4) hours. MEASUREMENTS AND MAIN RESULTS:. Endpoints included vital signs, patient- and nurse-reported signs and symptoms (stratified according to clinical significance), pulmonary function testing, 12-lead electrocardiogram, mini-mental state examinations, neurologic examination, and serologic testing prior to and following exposure. All adverse events were verified by two clinicians external to the study team and an external Data and Safety Monitoring Board. All eight participants (18–30 yr; 50% female; 62% non-Caucasian) completed the study without early termination. No clinically significant adverse events occurred in any patient. Compared with baseline measures, there were no clinically significant changes over time in vital signs, pulmonary function testing results, Mini-Mental State Examination scores, neurologic examination findings, electrocardiogram measurements, or serologic tests for hematologic (except for clinically insignificant increases in hematocrit and platelet counts), renal, hepatic, pancreatic, or cardiac injury associated with hydrogen gas inhalation. CONCLUSIONS:. Inhalation of 2.4% hydrogen gas does not appear to cause clinically significant adverse effects in healthy adults. Although these data suggest that inhaled hydrogen gas may be well tolerated, future studies need to be powered to further evaluate safety. These data will be foundational to future interventional studies of inhaled hydrogen gas in injury states, including following cardiac arrest.Alexis R. Cole, BSFrancesca Sperotto, MDJames A. DiNardo, MDStephanie CarlisleMichael J. Rivkin, MDLynn A. Sleeper, ScDJohn N. Kheir, MDWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 10, p e543 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Alexis R. Cole, BS
Francesca Sperotto, MD
James A. DiNardo, MD
Stephanie Carlisle
Michael J. Rivkin, MD
Lynn A. Sleeper, ScD
John N. Kheir, MD
Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
description BACKGROUND:. Ischemia-reperfusion injury is common in critically ill patients, and directed therapies are lacking. Inhaled hydrogen gas diminishes ischemia-reperfusion injury in models of shock, stroke, and cardiac arrest. The purpose of this study was to investigate the safety of inhaled hydrogen gas at doses required for a clinical efficacy study. DESIGN:. Prospective, single-arm study. SETTING:. Tertiary care hospital. PATIENTS/SUBJECTS:. Eight healthy adult participants. INTERVENTIONS:. Subjects underwent hospitalized exposure to 2.4% hydrogen gas in medical air via high-flow nasal cannula (15 L/min) for 24 (n = 2), 48 (n = 2), or 72 (n = 4) hours. MEASUREMENTS AND MAIN RESULTS:. Endpoints included vital signs, patient- and nurse-reported signs and symptoms (stratified according to clinical significance), pulmonary function testing, 12-lead electrocardiogram, mini-mental state examinations, neurologic examination, and serologic testing prior to and following exposure. All adverse events were verified by two clinicians external to the study team and an external Data and Safety Monitoring Board. All eight participants (18–30 yr; 50% female; 62% non-Caucasian) completed the study without early termination. No clinically significant adverse events occurred in any patient. Compared with baseline measures, there were no clinically significant changes over time in vital signs, pulmonary function testing results, Mini-Mental State Examination scores, neurologic examination findings, electrocardiogram measurements, or serologic tests for hematologic (except for clinically insignificant increases in hematocrit and platelet counts), renal, hepatic, pancreatic, or cardiac injury associated with hydrogen gas inhalation. CONCLUSIONS:. Inhalation of 2.4% hydrogen gas does not appear to cause clinically significant adverse effects in healthy adults. Although these data suggest that inhaled hydrogen gas may be well tolerated, future studies need to be powered to further evaluate safety. These data will be foundational to future interventional studies of inhaled hydrogen gas in injury states, including following cardiac arrest.
format article
author Alexis R. Cole, BS
Francesca Sperotto, MD
James A. DiNardo, MD
Stephanie Carlisle
Michael J. Rivkin, MD
Lynn A. Sleeper, ScD
John N. Kheir, MD
author_facet Alexis R. Cole, BS
Francesca Sperotto, MD
James A. DiNardo, MD
Stephanie Carlisle
Michael J. Rivkin, MD
Lynn A. Sleeper, ScD
John N. Kheir, MD
author_sort Alexis R. Cole, BS
title Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
title_short Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
title_full Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
title_fullStr Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
title_full_unstemmed Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults
title_sort safety of prolonged inhalation of hydrogen gas in air in healthy adults
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/cf8b816444ae4276b11b19d4aaec888d
work_keys_str_mv AT alexisrcolebs safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT francescasperottomd safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT jamesadinardomd safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT stephaniecarlisle safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT michaeljrivkinmd safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT lynnasleeperscd safetyofprolongedinhalationofhydrogengasinairinhealthyadults
AT johnnkheirmd safetyofprolongedinhalationofhydrogengasinairinhealthyadults
_version_ 1718413648124182528